Condition: Bone Metastasis · Oncology Pain · Sponsor: Institut de Cancérologie de Lorraine
The goal of this clinical trial is to assess the impact of reducing the volume of palliative metastatic bone irradiation on analgesic effectiveness at day 30 and to evaluate the efficiency of telemonitoring in identifying patients who could benefit from Patient-Reported Outcomes (PROs) and require care. These objectives will be addressed in a multicenter, randomized, prospective study with two arms: A standard arm with spinal irradiation without sparing the adjacent vertebrae. An experimental arm with spinal irradiation sparing the adjacent vertebrae. The results will determine whether reducing the irradiated volume can maintain effective pain relief while minimizing side effects.
This description comes directly from the study's public registry record.
Jean-Christophe JCF FAIVRE, MD. · +33383594072 · jc.faivre@nancy.unicancer.fr
Aurélien LAMBERT, MD. · +33383594123 · a.lambert@nancy.unicancer.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire de Brest | Brest, Brest, France | Recruiting |
| Centre Henri Becquerel Rouen | Rouen, Rouen, France | Recruiting |
| Institut de cancérologie de l'Ouest (ICO) | Saint-Herblain, Saint-Herblain, France | Recruiting |
| Institut de Cancérologie de Lorraine | Vandœuvre-lès-Nancy, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06884332